Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Plutavimab - Sorrento Therapeutics

Next Previous
Drug Profile

Plutavimab - Sorrento Therapeutics

Alternative Names: COVI-AMG™; STI-2020

Latest Information Update: 07 Mar 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sorrento Therapeutics
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action Virus internalisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II COVID 2019 infections

Most Recent Events

  • 25 Feb 2022 Sorrento Therapeutics withdraws a phase II trial for COVID-2019 infections in USA (Parenteral), as the company wants to conduct a new trial (NCT04734860)
  • 25 Feb 2022 Sorrento Therapeutics withdraws a Phase-II clinical trial in COVID-2019 infections in USA (Parenteral), as the company plans to conduct a new trial (NCT04771351)
  • 25 Feb 2022 Sorrento Therapeutics withdraws a planned phase I/II trial for COVID-2019 infections, prior to enrollment initiation, as the company plans to conduct a new trial (IV) (NCT04738175)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top